Drug Database
Back to search

Poland· PL-100509222

Clatra

A bilastin product containing bilastinum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.

ATC R06AX29

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedClatraATCR06AX29REGISTER NO.PL-100509222PACKS LISTED5CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bilastinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bilastin is registered in 11 of 19 countries.

Countries holding a registration under ATC R06AX29 (bilastin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search bilastin products by name

Bilastin · ATC R06AX29

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bilastin costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.14 in France to $0.45 in Switzerland — a ×3.3 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Bilastin · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.45
  • FR France$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Bilastinum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
R06AX29
ATC class
Bilastin
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909991560447
  • gtin
    05909991560454
  • gtin
    05909991560461
  • gtin
    05909991560478
  • gtin
    05909991560485

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bilastin in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bilastin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Bilastin Hyperpoll, Bilastin Tiefenbacher
  • Belgium · Bellozal, Bilastine Ab
  • Bulgaria · Bilastine Stada, Биластин Мсн
  • Cyprus · Alivixa, Bilastine Delorbis
  • Czechia · Abisax, Bilastin Stada
  • Germany · Allegra Allergietabletten, Allegra Allergietabletten Kinder
  • Denmark · Bilastine Stada, Revitelle
  • Estonia · Bilastin, Bilastine Stada
  • Spain · Abisax, Abrilia
  • Finland · Bilastine Stada, Revitelle
  • France · Bilaska, Bilastine Arrow
  • United Kingdom (Northern Ireland) · Bilastine Medreich, Bilastine Milpharm
  • Greece · Bilargen, Bilastine Stada
  • Croatia · Actine, Nixar
  • Hungary · Bilastine Supremex, Bilastine Teva
  • Ireland · Bilastine Clonmel, Bilhista
  • Iceland · Bilaxten
  • Italy · Alyne, Ayrinal
  • Lithuania · Belargan, Bilastine Sandoz
  • Luxembourg · Bellozal, Bilastine Eurogenerics
  • Latvia · Bilastine Stada, Bilpexo
  • Malta · Alivixa, Bilastine Clonmel
  • Norway · Bilastine Stada, Zilas
  • Portugal · Aelardis, Alostine
  • Romania · Bilastină Gemax Pharma, Bilastină Msn
  • Sweden · Bilacina, Bilastin Teva
  • Slovenia · Bilador, Bilastin Stada
  • Slovakia · Abisax, Bilastin Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bf38f939-e7b6-4df5-9d47-102b03ca62f0
GET /v1/drugs/bf38f939-e7b6-4df5-9d47-102b03ca62f0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "20 mg",
  "packaging": "05909991560447 ¦ Rp ¦ 159267\n20 tabl.\n05909991560454 ¦ Rp ¦ 159268\n40 tabl.\n05909991560461 ¦ Rp ¦ 159269\n50 tabl.\n05909991560478 ¦ Rp ¦ 159270\n10 tabl.\n05909991560485 ¦ Rp ¦ 159271\n30 tabl.",
  "substance": "Bilastinum 20 mg",
  "common_name": "Bilastinum",
  "pl_product_id": "100509222",
  "pozwolenie_nr": "429/24",
  "auth_procedure": "IR",
  "authorisation_validity": "2029-12-05"
}
API referenceMCP serverPlans

See everything about bilastin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console